Asian Medical And Research Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.85 Cr
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 7.01%
- Profit Growth 8.63%
- Ebitda 8.38%
- Net Worth 16.67%
- Total Assets 2.10%
About Asian Medical And Research
Asian Medical And Research Private Limited (AMARPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 July 2012 and has a history of 12 years and six months. Its registered office is in Kamrup, Assam, India.
The Corporate was formerly known as Jayanti Developers And Realtors Private Limited. The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Das, Vivek Sikka, and Sudhir Baruah serve as directors at the Company.
Company Details
-
Location
Kamrup, Assam, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U55101AS2012PTC011201
-
Company No.
011201
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jul 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Asian Medical And Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Sikka
|
Director | 02-May-2016 | Current |
|
Jitendra Das
|
Director | 02-May-2016 | Current |
|
Sudhir Baruah
|
Additional Director | 06-Aug-2024 | Current |
Financial Performance of Asian Medical And Research.
Asian Medical And Research Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.01% increase. The company also saw a slight improvement in profitability, with a 8.63% increase in profit. The company's net worth Soared by an impressive increase of 16.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asian Medical And Research?
In 2021, Asian Medical And Research had a promoter holding of 48.62% and a public holding of 51.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Daskside Solutions Private LimitedVivek Sikka is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asian Medical And Research?
Unlock and access historical data on people associated with Asian Medical And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asian Medical And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asian Medical And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
